NO880667L - Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.

Info

Publication number
NO880667L
NO880667L NO880667A NO880667A NO880667L NO 880667 L NO880667 L NO 880667L NO 880667 A NO880667 A NO 880667A NO 880667 A NO880667 A NO 880667A NO 880667 L NO880667 L NO 880667L
Authority
NO
Norway
Prior art keywords
arylpiperazinyl
alkylene
phenyl
procedure
preparation
Prior art date
Application number
NO880667A
Other languages
English (en)
Other versions
NO170582C (no
NO880667D0 (no
NO170582B (no
Inventor
John Adams Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO880667D0 publication Critical patent/NO880667D0/no
Publication of NO880667L publication Critical patent/NO880667L/no
Publication of NO170582B publication Critical patent/NO170582B/no
Publication of NO170582C publication Critical patent/NO170582C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
NO880667A 1987-02-17 1988-02-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser NO170582C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8700340 1987-02-17

Publications (4)

Publication Number Publication Date
NO880667D0 NO880667D0 (no) 1988-02-16
NO880667L true NO880667L (no) 1988-08-18
NO170582B NO170582B (no) 1992-07-27
NO170582C NO170582C (no) 1992-11-04

Family

ID=22202287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880667A NO170582C (no) 1987-02-17 1988-02-16 Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser

Country Status (30)

Country Link
EP (1) EP0279598B1 (no)
JP (1) JPH0699405B2 (no)
KR (1) KR900004126B1 (no)
CN (1) CN1015627B (no)
AP (1) AP88A (no)
AR (1) AR245125A1 (no)
AT (1) ATE94537T1 (no)
AU (1) AU583761B2 (no)
CA (1) CA1312080C (no)
CS (1) CS272783B2 (no)
DD (1) DD272080A5 (no)
DE (1) DE3884007T2 (no)
DK (1) DK170878B1 (no)
EG (1) EG18635A (no)
ES (1) ES2058249T3 (no)
FI (1) FI91752C (no)
HU (1) HU207731B (no)
IE (1) IE61258B1 (no)
IL (1) IL85368A0 (no)
IN (1) IN171858B (no)
MA (1) MA21183A1 (no)
MX (1) MX174210B (no)
MY (1) MY103210A (no)
NO (1) NO170582C (no)
NZ (1) NZ223530A (no)
PL (1) PL157118B1 (no)
PT (1) PT86766B (no)
SU (1) SU1634136A3 (no)
YU (1) YU46624B (no)
ZA (1) ZA881064B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5166156A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5166157A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
NZ307958A (en) * 1995-06-06 1999-02-25 Hoechst Marion Roussel Inc Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
EP0871619B1 (en) 1995-12-29 2002-11-06 Boehringer Ingelheim Pharmaceuticals Inc. Phenyl thiazole derivatives with anti herpes virus properties
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
WO1999001420A1 (fr) * 1997-07-03 1999-01-14 Taito Co., Ltd. Procede de preparation de derives d'acide 2-aminomalonique, et intermediaires utilises dans ce procede
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
GB948766A (en) * 1959-10-20 1964-02-05 May & Baker Ltd Trifluoromethylphenylpiperazine derivatives
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
JPS5910675B2 (ja) * 1976-03-22 1984-03-10 ウェルファイド株式会社 アラルキルアミン誘導体
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物

Also Published As

Publication number Publication date
AP88A (en) 1990-06-06
FI91752B (fi) 1994-04-29
CS272783B2 (en) 1991-02-12
KR900004126B1 (ko) 1990-06-16
JPH0699405B2 (ja) 1994-12-07
JPS63216875A (ja) 1988-09-09
MA21183A1 (fr) 1988-10-01
CS96488A2 (en) 1990-04-11
YU30388A (en) 1989-10-31
ES2058249T3 (es) 1994-11-01
CN1015627B (zh) 1992-02-26
DK78888D0 (da) 1988-02-16
HU207731B (en) 1993-05-28
NO170582C (no) 1992-11-04
EP0279598A3 (en) 1989-07-26
PL270653A1 (en) 1988-12-08
IE880420L (en) 1988-08-17
DK78888A (da) 1988-08-18
EG18635A (en) 1994-04-30
KR880009964A (ko) 1988-10-06
CA1312080C (en) 1992-12-29
IN171858B (no) 1993-01-23
SU1634136A3 (ru) 1991-03-07
ATE94537T1 (de) 1993-10-15
CN88100986A (zh) 1988-09-21
YU46624B (sh) 1994-01-20
AU583761B2 (en) 1989-05-04
PL157118B1 (pl) 1992-04-30
AP8800082A0 (en) 1988-02-01
DE3884007T2 (de) 1994-01-20
NO880667D0 (no) 1988-02-16
PT86766B (pt) 1992-05-29
DD272080A5 (de) 1989-09-27
DE3884007D1 (de) 1993-10-21
AU1174088A (en) 1988-08-18
EP0279598B1 (en) 1993-09-15
IE61258B1 (en) 1994-10-19
NO170582B (no) 1992-07-27
DK170878B1 (da) 1996-02-26
ZA881064B (en) 1989-09-27
FI880716A (fi) 1988-08-18
PT86766A (pt) 1988-03-01
NZ223530A (en) 1990-07-26
AR245125A1 (es) 1993-12-30
FI880716A0 (fi) 1988-02-16
EP0279598A2 (en) 1988-08-24
FI91752C (fi) 1994-08-10
HUT50334A (en) 1990-01-29
MY103210A (en) 1993-05-29
MX174210B (es) 1994-04-28
MX10428A (es) 1993-09-01
IL85368A0 (en) 1988-07-31

Similar Documents

Publication Publication Date Title
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO884473L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees